Preclinical activities of Cassia tora Linn against aging-related diseases

Expert Rev Mol Med. 2022 Oct 25:24:e43. doi: 10.1017/erm.2022.33.

Abstract

Globally, an aging population is increasing, and aging is a natural physiological process and a major risk factor for all age-related diseases. It seriously threatens personal health and imposes a great economic burden. Therefore, there is a growing scientific interest in strategies for well-aging with prevention and treatment of age-related diseases. The seed, root, stem or leaves of Cassia tora Linn. are useful for anti-bacteria, anti-hyperlipidemia and anti-obesity due to its pharmacological activities such as anti-inflammation and anti-oxidant both in vitro and in vivo. Nevertheless, no clinical trials have been attempted so far, therefore here we would like to understand the current preclinical activities for aging-related disease models including cataract, metabolic dysfunction and neurodegeneration, then discuss their preparation for clinical trials and perspectives.

Keywords: Animal model; Cassia tora Linn; antioxidant; disease; preclinical.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aging
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Cassia* / metabolism
  • Cataract* / drug therapy
  • Cataract* / metabolism
  • Humans
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Plant Extracts
  • Antioxidants